SDS Biotech K.K. announced consolidated earnings results for the first quarter ended March 31, 2014. For the quarter, the company's net sales were ¥3,673 million compared with ¥2,513 million a year ago. Operating income was ¥405 million compared with ¥191 million a year ago. Ordinary income was ¥338 million compared with ¥186 million a year ago. Net income was ¥210 million or ¥26.83 per diluted share compared with ¥123 million or ¥15.80 per diluted share a year ago. As on March 31, 2014, the company's net assets per share was ¥626.00. Net income before taxes for the quarter was ¥338.8 million compared with ¥185.8 million a year ago.

For the year ending December 31, 2014, the company forecasts net sales of ¥14,866 million, operating income of ¥1,352 million, ordinary income of ¥1,179 million, net income of ¥684 million or ¥87.35.